Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chirag D Jhaveri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2013
Suprachoroidal silicone oil migration following retinal detachment repairNataliya Danylkova, Nitasha Gupta, Chirag D Jhaveri, et al.
Retina (Philadelphia, Pa.)|February 21, 2012
Diagnostic and therapeutic challengesChirag D Jhaveri, Lee M Jampol, Russell N Van Gelder, et al.
Retina (Philadelphia, Pa.)|December 19, 2021
EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER StudiesPravin U Dugel, Chirag D Jhaveri, Usha Chakravarthy, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 16, 2022
Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial ExperienceArshad M Khanani, Jordan M Graff, Dennis M Marcus, et al.
Retina (Philadelphia, Pa.)|October 1, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical TrialsNeil M Bressler, Wesley T Beaulieu, Susan B Bressler, et al.
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology|March 26, 2019
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized TrialJayashree Sahni, Sunil S Patel, Pravin U Dugel, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2013
Suprachoroidal silicone oil migration following retinal detachment repairNataliya Danylkova, Nitasha Gupta, Chirag D Jhaveri, et al.
Retina (Philadelphia, Pa.)|February 21, 2012
Diagnostic and therapeutic challengesChirag D Jhaveri, Lee M Jampol, Russell N Van Gelder, et al.
Retina (Philadelphia, Pa.)|December 19, 2021
EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER StudiesPravin U Dugel, Chirag D Jhaveri, Usha Chakravarthy, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 16, 2022
Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial ExperienceArshad M Khanani, Jordan M Graff, Dennis M Marcus, et al.
Retina (Philadelphia, Pa.)|October 1, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical TrialsNeil M Bressler, Wesley T Beaulieu, Susan B Bressler, et al.
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology|March 26, 2019
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized TrialJayashree Sahni, Sunil S Patel, Pravin U Dugel, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
Pageof 1